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mutations within the COL6A1 gene C-Terminal
domain: a case report
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Background: Mutations within the C-terminal region of the COL6A1 gene are only detected in Ullrich/Bethlem
patients on extremely rare occasions.
Case presentation: Herein we report two Brazilian brothers with a classic Ullrich phenotype and compound
heterozygous for two truncating mutations in COL6A1 gene, expected to result in the loss of the α1(VI) chain C2
subdomain. Despite the reduction in COL6A1 RNA level due to nonsense RNA decay, three truncated alpha1 (VI)
chains were produced as protein variants encoded by different out-of-frame transcripts. Collagen VI matrix was
severely decreased and intracellular protein retention evident.
Conclusion: The altered deposition of the fibronectin network highlighted abnormal interactions of the mutated
collagen VI, lacking the α1(VI) C2 domain, within the extracellular matrix, focusing further studies on the possible
role played by collagen VI in fibronectin deposition and organization.
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Collagen type VI is a widespread heterotrimeric extracellu-
lar matrix glycoprotein; it is mainly present in the stroma,
but it also forms a microfibrillar network in close asso-
ciation with the basement membrane of most tissues [1].
Its subunits, the α1(VI), α2(VI), and α3(VI) chains, are
encoded by the COL6A1, COL6A2 (chr.21q22.3) [2,3] and
COL6A3 (chr.2q37) [3] genes respectively and share a cen-
tral triple-helix (TH) domain with repeating Gly-Xaa-Yaa
sequences flanked by N- and C-globular domains [4-6].
Formation of collagen VI is a complex multi-step process:
inside the cells, the equimolar association of the three
subunits to form a triple-helical monomer is followed by
assembly into disulphide-bonded anti-parallel dimers,
which then align to form tetramers, also stabilized by* Correspondence: mrtlne@unife.it
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reproduction in any medium, provided the ordisulphide bonds. Outside the cell, the tetramers, the se-
creted form of collagen VI, associate end-to-end through
overlapping N-terminal globular domains, thereby forming
double-beaded microfibrils [1].
Mutations in the COL6A1, COL6A2, and COL6A3
genes cause collagen VI-related myopathies, a group of
allelic disorders exhibiting a variable combination of
muscle wasting and weakness, joint contractures, distal
laxity, and respiratory compromise [7-9].
Ullrich congenital muscular dystrophy (UCMD, OMIM
#254090), caused by both inherited recessive and dominant
de novo COL6 mutations, is the most severe of these disor-
ders. In UCMD patients, collagen VI is typically reduced
or absent in the muscle and in cultured skin fibroblasts
[10-12]. The majority of COL6 gene mutations reported in
UCMD patients result in premature termination codons
[7,8; Leiden Muscular Dystrophy pages http://www.dmd.nl/
col6a1, http://www.dmd.nl/col6a2, and http://www.dmd.nl/
col6a3]. In addition, missense mutations substitutingl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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reported [7,8,13], as well as splicing mutations leading to
in-frame exon deletions [7,8,14].
Although clear mutational hot spots have not been
identified, exon 10 of COL6A1, exon 26 of COL6A2 and
intron 16 of COL6A3 seems to be preferentially mutated
[8] and the topographical distribution of mutations along
the different protein domains differs between the chains.
In the α2(VI) chain, mutations have been described
affecting N-terminal, TH and C-terminal domains to a
similar degree. In contrast, mutations in α1(VI) and α3
(VI) chains are almost exclusively located in the TH and
N-terminal domains, with just few in frame deletions
and missense changes affecting the C-terminal regions
have been described and in general mutations in these
C-domains being very rare [8; Leiden Muscular Dystrophy
pages http://www.dmd.nl/col6a1, http://www.dmd.nl/col6a2
and http://www.dmd.nl/col6a3]. Indeed, no truncating mu-
tations have been described in this domain of the α3(VI)
chain, and only one case of UCMD carrying a homozygous
truncating mutation within the a1(VI) chain C-terminus
has been reported [15].
In this study we characterize the clinical, transcrip-
tional, immunohistochemical and biochemical features
of a rare example of truncating mutations within the C-
terminal domain of the COL6A1 gene, detected in two
Brazilian brothers with UCMD.
Case presentation
The two Brazilian brothers both have a clinical diagnosis
of UCMD; they were born from non-related parents,
neither of whom reported a family history of neuromus-
cular diseases. The eldest patient was unable to walk
autonomously until he was 3 years of age, whereupon he
consistently showed a waddling gait, a severe difficulty
in climbing stairs and rising from the floor, and a total
inability to run. At the age of 5 he lost the ability to
walk. Clinical examination at 9 years evidenced: severe
muscle weakness, predominantly involving proximal
muscles, marked hyperlaxity of the skin and distal jointsFigure 1 Clinical presentation of the youngest sib: a) The patient is u
hyperlaxity of fingers.and contractures of the knees and elbows. Respiratory
function and serum CK were normal, and no significant
scoliosis was reported.
The youngest sib has a similar clinical presentation
but, differently from the brother, he was never able to
walk. At the age of examination (5 years), he was com-
pletely unable to lift his arms or legs against the force of
gravity. He also displayed skin and joint hyperlaxity
(Figure 1) and mild contractures of the hips and knees.
Neither scoliosis nor respiratory problems were evident.
Methods
DNA and RNA analyses
The study was approved by the local ethics committee
(Comitato Etico Della Provincia di Ferrara). Genomic
sequencing of COL6 genes was performed, as previously
described, on both patients [16].
Total RNA was isolated from confluent skin fibroblasts
from the eldest patient by RNeasy Kit (QIAGEN). RT-
PCR was performed as previously described [9], using
amplification primers within exons 26, 31, 32 and 35 of
the COL6A1 gene. RT-PCR products were sequenced
either directly or subsequent to cloning into pCRII -
TOPO vector (Invitrogen).
Real-Time PCR was performed on cDNA from fi-
broblasts, using TaqMan expression assays for the
three COL6A genes (COL6A1: Hs01095581_g1 Ex 16-
17; COL6A2: Hs00964570_g1 ex 13–14; COL6A3:
Hs00915102_m1 Ex 23–24 from Applied Biosystems)
and for actin as a reference gene (ACTB Endogenous
Control), as previously described [9].
Immunofluorescence and confocal microscopy analysis on
skin fibroblasts
Dermal fibroblast cultures were obtained from skin
biopsy explants from the eldest patient as previously
described [17]. Confluent cells were incubated with an
anti-collagen VI antibody (MAB1944, Millipore, Temecula,
CA), followed by AlexaFluor 488/anti-mouse IgG (Invitro-
gen, Molecular Probes, Carlsbad, CA). In double-stainingnable to lift his arms against the force of gravity; b) detail on
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fibronectin antibody (Santa Cruz), followed by AlexaFluor
555/anti-goat IgG (Molecular Probes). The other samples
were formaldehyde fixed, permeabilized with 0.15% Triton
X-100, and incubated with MAB1944 antibody. Nuclei
were counterstained with Hoechst (Molecular Probes) or
DRAQ5 (Biostatus, UK). Slides were mounted with Pro-
Long anti-fade reagent (Molecular Probes).
Confocal imaging was performed using Olympus
Fluoview FV1000 confocal IX81 microscope, using a 20×
objective lens (0.75 N.A.). Colocalization analysis and
image processing were carried out as reported [17].
Electron microscopy of secreted collagen VI
After 10 days’ treatment with 0.25 M ascorbic acid
(to allow collagen VI secretion), cultured fibroblasts
from the eldest sibling were incubated with a monoclo-
nal anti-collagen VI antibody (Chemicon), diluted 1:25
with Dulbecco’s modified Eagle medium, and 5 nm
colloidal gold-labelled IgG (Amersham). Rotary shadowing
electron microscopy was performed as previously des-
cribed [18]. Replicas were observed under a Phillips
EM400 electron microscope operating at 100Kv.
Immunoblotting of skin fibroblast-derived collagen VI
Fibroblasts were grown in the presence or absence of L-
ascorbic acid; the medium and cell layer were collected
from confluent cultures, and Western blot was performed
under reducing conditions as previously described [9].
Antibodies used were: a polyclonal antiserum recognizing
all collagen VI chains (Fitzgerald, 7CR-CR009X, lot x
11040530) and a polyclonal antiserum against human α3
(VI) chains (donated by Raimund Wagener, University
of Cologne). An antibody against GAPDH (Millipore,
MAB437) was used as a loading control. Analysis of the
media has been performed using comassie blu stained gel.
Results
DNA and RNA analyses
DNA analysis of the UCMD brothers revealed a com-
pound heterozygosis for recessive COL6A1 mutations: an
insertion within exon 33 (c.2331 ins/dup GCCT) of
maternal origin, and a G>C substitution affecting the
intron 32 donor splice site (c. 2148+1; NM_001848)
inherited from the father.
Transcriptional analysis on RNA from cultured fib-
roblasts from the eldest patient, revealed multiple
COL6A1 out-of-frame transcripts resulting from diffe-
rent pathological events: exon-32 skipping (K688fsX52),
intron-32 retention (Q750fsX13) and exon-33 hetero-
zygous ins/dup GCCT (L777PfsX52) (Figure 2a and
Additional file 1: Figure S1).
The in-frame stop-codons resulting from the identified
mutations fell either within the C1 subdomain or withinthe cysteine-rich connecting region. Consequently, the
overall predicted effects consisted of the production of
truncated α1(VI) chains selectively lacking the C2
subdomain of the C-terminal region (Figure 2b).
Real-Time PCR showed a strong reduction in the
aberrant COL6A1 transcripts with respect to non-
mutated COL6A2 and COL6A3 mRNA. In contrast, the
ratio between the levels of COL6A2 and COL6A3 mRNA
was similar to that observed in an unaffected control
(Figure 2c).Immunofluorescence and electron microscopy
After 4 days of ascorbate treatment, the total amount of
collagen VI matrix in cultured UCMD fibroblasts was sig-
nificantly reduced (Figure 3c), and microfibrils displayed a
punctuate and discontinuous appearance (Figure 3c,
inset). Permeabilization of cellular samples revealed an
abnormal intracellular retention of collagen VI in the
majority of UCMD fibroblasts (Figure 3g). After 10 days
of ascorbate treatment, no effect on the discontinuous and
punctuate distribution of collagen VI network was obser-
ved in the UCMD matrix, although some groupings of mi-
crofibrils into short microfilaments were detectable
(Figure 4e, arrows). Additionally, fibrils from the fibronec-
tin matrix were short and less copious (Figure 4f), and
scarce colocalization between fibronectin fibrils and the
rare bundles of collagen VI microfilaments was evident
(Figure 4g inset).
After 10 days of L-ascorbic acid treatment, exami-
nation by transmission electron microscopy revealed
short collagen VI microfibrils which appeared unable to
develop regular webs (Figure 5a A, B). Ring structures
constituted by single collagen VI microfilaments were
also detected (Figure 5a A inset). Short collagen VI
fibrils, constituted by parallel microfibrils, were occa-
sionally found, and the globular domains of adjacent
microfibrils were not regularly aligned as in control
fibroblasts (Figure 5a C, D).Western blot analysis
In the UCMD cell layer, besides bands corresponding to α3
(VI) and α2(VI) chains, we identified three bands migrating
at about 120 kDa, 100 kDa and 90 kDa (Figure 5b A). The
estimated molecular weight of these three bands corres-
pond to the expected migration for the protein variants
coded by the different out-of-frame transcripts produced
by patients cells. Interestingly, none of these truncated pro-
tein variants were detected in the conditioned medium of
patient cells (Figure 5b, B). The amount of collagen VI
detected in the cell layer from the patient was similar to
control (Figure 5b, A). In contrast, the patient medium was
found to contain significantly less collagen VI than that of
the unaffected donor (Figure 5b, B).
Figure 2 Schematic rappresentation of aberrant transcripts and protein products, and relative quantification of the mutated COL6A1
messenger. a) Schematic representation of the out-of-frame COL6A1 transcripts deriving from the two alleles carrying the mutated intron 32
c.2250+1 (allele 1) and exon 33 c.2331 Ins/Dup GCCT (allele 2). The in-frame stop-codons recognized as an effect of the frame-shifting mutations
are indicated. b) Schematic representations of the predicted protein products arising from the identified mutations. All truncated a1 (VI) chains
lack the C2 subdomain. c) Relative quantification of the mutated COL6A1 messenger with respect to COL6A2 and COL6A3 wild-type transcripts.
COL6A1 RNA was reduced to 15% of COL6A2 and COL6A3 mRNA levels, while the COL6A2/COL6A3 ratio (1:1) was similar to that displayed by an
unaffected control.
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Mutations occurring in the C-terminal region of the
COL6A1 gene are exceptionally rare. The few missense
changes reported in this region exhibit the allele
frequencies of common polymorphisms [7,8] Leiden
Muscular Dystrophy pages [http://www.dmd.nl/], and
only a single case of truncating mutation has been
reported to date ([15] Patient P2). This UCMD patient,
described by Giusti et al. carries an homozygous non-
sense mutation within COL6A1 exon 31 (Tyr659X),
causing an out-of-frame skipping of the mutated exon in
15% of the transcripts. Collagen VI was absent in the
muscle, and Western blot analysis of cultured cells failed
to detect the α1(VI) chain in either cells or medium.
We investigated the transcriptional, immunohisto-
chemical and biochemical behaviour of two truncating
mutations within the C-terminal region of the COL6A1
gene occurring in compound heterozygosis in two
UCMD brothers born from healthy parents.
Transcriptional analysis revealed the occurrence of
multiple aberrant out-of-frame COL6A1 transcripts
which, despite the dramatic reduction of COL6A1 RNAdue to nonsense RNA decay, give rise to truncated pro-
tein products, predicted to lack the α1(VI) C2
subdomain, as detectable by Western blot analysis. This
behaviour was reflected in the severe reduction in col-
lagen VI matrix seen in cultured fibroblasts, and in the
abnormal intracellular retention observed.
A variety of studies have highlighted the importance of
C-terminal interactions in the alpha1(VI), alpha2(VI)
and alpha3(VI) chains in chain selection, association and
triple helix formation [19]. In the extracellular matrix of
our patient cultures, a minute amount of collagen VI
could be detected, as indicated by immunofluorescence
and electron microscopy, suggesting that the absence of
alpha1(VI) C2 domain does not entirely impair the asso-
ciation of mutant protein with alpha2 and alpha3 chains.
However, our finding that the secreted tetramers do not
form extensive networks indicates that the alpha1(VI)
C2 domain is critical for tetramer alignment and interac-
tions with other components of the extracellular matrix.
Although the precise protein interactions in the organi-
zation of collagen VI in the extracellular matrix remain
unclear, fibronectin is known to interact with the alpha1
Figure 3 Confocal laser microscopy of the collagen VI matrix in control and UCMD-confluent dermal fibroblasts after 4-days of L-ascorbic
acid treatment. In vivo staining of the collagen VI network in control fibroblasts detected a normal quantity and a parallel alignment of collagen VI
microfibrils (a), whereas UCMD cells secreted a decreased amount of collagen VI (c), and microfibrils showed a punctuate and discontinuous pattern
of deposition (arrows, inset). In fixed and permeabilized samples, collagen VI immunofluorescence detected a significant intracellular retention in the
majority of UCMD fibroblasts (g), whereas control cells exhibited a normal collagen VI deposition (e). Cell density was checked by counterstaining with
Hoechst (b, f, d, h). Scale bar: 50 μm.
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Figure 4 Double immunolabelling with collagen VI and fibronectin antibodies. Double immunolabelling with collagen VI (green) and
fibronectin (red) antibodies of the extracellular matrix secreted by cultured dermal fibroblasts from control (a-c) and UCMD patient (e-g) after 10
days of ascorbate treatment. Phase contrast images of control (d) and UCMD (h) fibroblasts showed the state of cell confluence (nuclei were
stained with Hoechst, in insets). In control cells, collagen VI (a) and fibronectin (b) networks showed a similar distribution pattern and colocalized
in several points, as revealed by their merge signal (yellow, high magnification in the inset). UCMD fibroblasts secreted a decreased amount of
collagen VI matrix (e) with rare bundles of short microfilaments (e, arrows). UCMD cells produced an altered fibronectin network with short and
irregularly aligned fibrils (f), and the colocalization with the collagen VI matrix was significantly impaired (g, high magnification in the inset).
Nuclei were stained with DRAQ5 (pseudocolored in blue in c and g). Scale bar: 50 μm.
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Figure 5 Electron microscopy and western blot of Collagen VI. a) Electron microscopy of collagen VI secreted by fibroblasts from the UCMD
patient (A, C) and controls (B, D). Collagen VI microfibrils from the patient (A, arrows) appear randomly deposited in the extracellular matrix, and
unable to interconnect and develop regular webs with respect to normal fibroblasts (B). A ring structure constituted by a single microfilament is
shown in the inset in panel A. Collagen VI fibrils from the patient are disorganized, and poor alignment was detected in the globular domains of
parallel microfibrils (C, arrows). In contrast, fibrils from normal fibroblasts show the typical regular beaded organization and parallel association of
globular domains (D, arrows). Scale bars: 400 nm in A-B, and 100 nm in C-D. b) Western blot of collagen VI in cell layer and medium of the
UCMD patient and a healthy donor. Samples derived from skin fibroblasts of the patient (UCMD) and a healthy donor (CTRL), were separated by
SDS-PAGE onto 3-8% polyacrylamide under reducing conditions. The molecular weight markers (kDa) are indicated on the left. The arrows point
to the three truncated α1 (VI) products, while the asterisk refers to a non-specific band. The loading control in the cell layer samples was
performed using a GAPDH antibody. The expected migration of collagen VI chains are indicated on the right.
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volves the globular domain of collagen VI, which contains
the amino and carboxyl-terminal domains, and fibronectin
three-dimensional arrangement is modulated by collagen
VI deposition [21]. Interestingly, fibronectin organization
was found to be altered in the extracellular matrix of the
analysed patient indicating that the α1(VI) C2 domainmight be involved in fibronectin deposition and orga-
nization. Previous studies suggested that a defective se-
cretion and deposition of collagen VI may impair the
organization of fibronectin fibrils [21] in the extracellular
matrix of cultured fibroblasts, as well as smaller amount
of fibronectin protein may be detected in the UCMD
matrix respecting to control cells [17].
Martoni et al. BMC Medical Genetics 2013, 14:59 Page 8 of 9
http://www.biomedcentral.com/1471-2350/14/59Conclusions
Considering the high frequency of mutations affecting the
COL6A2 C-domain, the rarity of UCMD/BM mutations
involving the COL6A1 C-terminal region is intriguing,
especially in view of the structural and evolutionary simi-
larities between COL6A1 and COL6A2 genes, and thus
far remains unexplained [22]. Based on their location in
the same region of chromosome 21, it has been suggested
that the two genes derive from a duplication of a prim-
ordial collagen VI gene; this hypothesis would explain
the highly similar exon structure of their triple helical
domains and the similar structure of α1(VI) and α2 (VI)
chains [23]. However, these genes differ in the region
encoding the globular domains [22], and conservation in
the C-terminus is limited to the region containing the
cysteine residues essential for correct collagen assembly.
This divergence could reflect disparate, still unclarified,
functional roles of the α1 (VI) and α2 (VI) C2 domains in
the context of collagen VI interactions within the extracel-
lular matrix, also possibly justifying the different contri-
bution of C-terminal mutations of the two proteins to
collagen VI-related phenotypes. The altered deposition of
the fibronectin network highlighted abnormal interactions
of the mutated collagen VI, lacking the α1(VI) C2 domain,
within the extracellular matrix, focusing further studies on
the possible role played by collagen VI in fibronectin
deposition and organization.
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